Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer

Ovarian cancer (OC) is estimated to kill ~14,000 women in the United States in 2019. Current chemotherapies to treat OC initially show therapeutic efficacy but frequently drug resistance develops, at which point therapies with alternative targets are needed. Herein, we are describing a novel approac...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Tiangong, Tang, Jianming, Shrestha, Binita, Heath, Blake R., Hong, Li, Lei, Yu L., Ljungman, Mats, Neamati, Nouri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295058/
https://www.ncbi.nlm.nih.gov/pubmed/32550915
http://dx.doi.org/10.7150/thno.41792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295058/
https://www.ncbi.nlm.nih.gov/pubmed/32550915
http://dx.doi.org/10.7150/thno.41792

Ejemplares similares